Florida says Kansas company dealt in suspect drugs
Fort Lauderdale Sun Sentinel, FL - 9 hours ago
... In one February example, state agents seized an Albers shipment of 200 bottles
of the mental health drug Zyprexa with sticky labels and discolored packages ...

Florida says Kansas company dealt in suspect drugs
South Florida Sun-Sentinel, FL - 9 hours ago
... In one February example, state agents seized an Albers shipment of 200 bottles
of the mental health drug Zyprexa with sticky labels and discolored packages ...

Defense: Crash was 'unavoidable'
Lowell Sun, MA - Aug 1, 2003
... Three other drugs Topomax, Zyprexa and Effexor are not included under the
felony charges, but could apply to the driving-to-endanger charge. ...

Fatal crash suspect on tape: 'I wish I had died'
Ayer Public Spirit, MA - Aug 1, 2003
... In addition, Reynolds admitted to police in her taped statement that she was taking
Topomax and Zyprexa, both mood stabilizers, and Effexor, an anti-depressant ...

Fatal crash suspect on tape: 'I wish I had died'
Townsend Times, MA - Aug 1, 2003
... In addition, Reynolds admitted to police in her taped statement that she was taking
Topomax and Zyprexa, both mood stabilizers, and Effexor, an anti-depressant ...

Fatal crash suspect on tape: 'I wish I had died'
Shirley Oracle, MA - Aug 1, 2003
... In addition, Reynolds admitted to police in her taped statement that she was taking
Topomax and Zyprexa, both mood stabilizers, and Effexor, an anti-depressant ...

Fatal crash suspect on tape: 'I wish I had died'
Groton Landmark, MA - Aug 1, 2003
... In addition, Reynolds admitted to police in her taped statement that she was taking
Topomax and Zyprexa, both mood stabilizers, and Effexor, an anti-depressant ...

Fatal crash suspect on tape: 'I wish I had died'
Harvard Hillside, MA - Aug 1, 2003
... In addition, Reynolds admitted to police in her taped statement that she was taking
Topomax and Zyprexa, both mood stabilizers, and Effexor, an anti-depressant ...

KC drug wholesaler faces uncertain future as legal problems mount
Kansas City Star, MO - Aug 1, 2003
... Robert Daniti, a legal adviser to the department's bureau of statewide pharmaceutical
services, said Albers was found to have sold bottles of Zyprexa, a ...

But Dip in US
Mind Horizons, TX - Jul 31, 2003
LLY.N , makers of the top-selling schizophrenia drug, Zyprexa, have reported a
five percent increase in overseas sales of the drug for the second quarter. ...

Cardinal Health Reports Record Fourth Quarter And Fiscal Year ...
Yahoo News (press release) - Jul 31, 2003
... Revenue gains were particularly strong in oral and sterile drug manufacturing, which
experienced solid growth from Lilly's Zyprexa® Zydis®, Mylan's Amnesteem ...

Fatal-crash suspect on tape: 'I wish I had died'
Lowell Sun, MA - Jul 30, 2003
... In addition, Reynolds admitted to police in her taped statement that she was taking
Topomax and Zyprexa, both mood stabilizers, and Effexor, an anti-depressant ...

Judge sides with patient
Akron Beacon Journal, OH - Jul 30, 2003
... Dr. Dongmin Kim, who has treated Black since she arrived at the hospital, wanted
Black to resume taking Zyprexa, Prolixin, Cogentin and Ativan, all narcotic ...

Bitter Orange Could Mean Red Alert With Some Drugs
Newsday - Jul 29, 2003
... depression. But lately I've developed paranoid thoughts and feelings.
My psychiatrist just started me on a drug called Zyprexa. It ...

ELI-LILLY and Company: parere positivo del CPMP europeo su nuova ...
PR Line (Comunicato Stampa), Italy - Jul 28, 2003
... medicinali (CPMP - European Committee for Proprietary Medicinal Products) ha pubblicato
un parere positivo su una nuova indicazione per il prodotto Zyprexa(R ...

Committee endorses new Eli Lilly drug indication
Forbes - Jul 28, 2003
... news - people) said on Monday that the European Committee for Proprietary Medicinal
Products has issued a positive opinion for a new indication for Zyprexa ...

Committee endorses new Eli Lilly drug indication
Reuters, UK - Jul 28, 2003
... and Company LLY.N said on Monday that the European Committee for Proprietary Medicinal
Products has issued a positive opinion for a new indication for Zyprexa ...

Eli Lilly and Company : New Indication for Zyprexa Receives ...
Business Wire (press release) - Jul 28, 2003
... NYSE:LLY) announced today that the European Committee for Proprietary Medicinal Products
(CPMP) has issued a positive opinion for a new indication for Zyprexa(R ...

Counterfeit drugs and the good life
Newark Star Ledger, NJ - Jul 26, 2003
... During the course of the investigation, Mann said, his team seized about $18 million
worth of high-end prescription drugs, including Zyprexa for schizophrenia ...

AT&T profit tops forecast
San Mateo County Times, CA - Jul 25, 2003
... Sales of Lilly's competing Zyprexa product topped $1 billion, pushing
net income up 5.1 percent at the Indianapolis-based drugmaker. ...

AT&T profit tops forecast
Oakland Tribune, CA - Jul 25, 2003
... Sales of Lilly's competing Zyprexa product topped $1 billion, pushing
net income up 5.1 percent at the Indianapolis-based drugmaker. ...

Business briefs
Denver Post, CO - Jul 25, 2003
... Eli Lilly & Co., the maker of Prozac antidepressants, said profit climbed 5.1 percent
in the second quarter as sales of the company's Zyprexa schizophrenia ...

Lowering the cost of drugs
Charlotte Observer, NC - Jul 25, 2003
... The illegal drug traders have even passed off sterile water as the cancer drug Neupogen
and aspirin as the schizophrenia drug Zyprexa.Tampered vials of Epogen ...

Zyprexa sales pace solid quarter at Lilly
Indianapolis Star, IN - Jul 24, 2003
... 1 product Zyprexa, which now contributes a third of Lilly's revenue.
"Zyprexa is obviously the key" to Lilly's recovery from the ...

American revival spurred by upbeat results
Guardian, UK - Jul 24, 2003
... In the pharmaceuticals sector, Eli Lilly said quarterly earnings rose 5%, with Zyprexa,
its best-selling treatment for schizophrenia, achieving sales of over $1 ...

Lilly posts 5 percent earnings gain in 2Q
Seattle Post Intelligencer, WA - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Lilly Posts 5 Percent Earnings Gain in 2Q
ABC News - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Lilly Posts 5 Percent Earnings Gain in 2Q
Austin American Statesman, TX - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Lilly Posts 5 Percent Earnings Gain in 2Q
Atlanta Journal Constitution, GA - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Bristol-Myers Profit Beats Dismal '02
Washington Post, DC - Jul 24, 2003
... Earnings also got a lift from its new schizophrenia treatment, Abilify,
which is stealing sales from rival Eli Lilly and Co.'s Zyprexa. ...

Eli Lilly Profits Helped by Zyprexa
MSN Money - Jul 24, 2003
... Research, a unit of Reuters Group Plc. Global sales of Zyprexa for schizophrenia
rose 15 percent. Overseas sales jumped 45 percent to ...

Eli Lilly Profits Helped by Zyprexa
Reuters, UK - Jul 24, 2003
... Research, a unit of Reuters Group Plc. Global sales of Zyprexa for schizophrenia
rose 15 percent. Overseas sales jumped 45 percent to ...

Bristol-Myers Profit Beats Dismal '02
Reuters, UK - Jul 24, 2003
... Earnings also got a lift from its new schizophrenia treatment, Abilify,
which is stealing sales from rival Eli Lilly and Co.'s LLY.N Zyprexa. ...

Bristol-Myers Profit Beats Dismal '02
MSN Money - Jul 24, 2003
... Earnings also got a lift from its new schizophrenia treatment, Abilify,
which is stealing sales from rival Eli Lilly and Co.'s (LLY) Zyprexa. ...

Lucent's Unlucky 13
Motley Fool - Jul 24, 2003
... Eli Lilly (NYSE LLY) announced Q2 EPS up slightly year over year from $0.61 to $0.64
on an 11% rise in revenue driven by sales of schizophrenia drug Zyprexa. ...

Schaeffer's Midday Options Update Features T , LLY , IP , . . .
Stock World, Germany - Jul 24, 2003
... The company saw a 15-percent rise in sales of its Zyprexa drug, which topped
$1 billion for the first time. Shares of LLY gapped higher on the news. ...

Drugmakers Deliver Profits, Shares Rise
FOX News - Jul 24, 2003
... the treatments. Lilly's Zyprexa (search), the market leader, logged
sales of $1.05 billion for the quarter, up 15 percent. But US ...

Schaeffer's Midday Options Update Features T, LLY, IP, SBC, S
Yahoo News (press release) - Jul 24, 2003
... The company saw a 15-percent rise in sales of its Zyprexa drug, which topped
$1 billion for the first time. Shares of LLY gapped higher on the news. ...

Drugmakers Deliver Profits, Shares Rise
Reuters, UK - Jul 24, 2003
... over the treatments. Lilly's Zyprexa, the market leader, logged sales
of $1.05 billion for the quarter, up 15 percent. But US sales ...

Bristol-Myers Second-Quarter Net Surges on Heart Drug (Update4)
Bloomberg - Jul 24, 2003
... said second-quarter sales of its schizophrenia treatment Zyprexa rose 2 percent
in the US, down from a 21 percent gain a year ago, because of the new ...

Big drugmakers deliver higher profits, shares rise
Forbes - Jul 24, 2003
... over the treatments. Lilly's Zyprexa, the market leader, logged sales
of $1.05 billion for the quarter, up 15 percent. But US sales ...

Big drugmakers deliver higher profits, shares rise
Reuters, UK - Jul 24, 2003
... over the treatments. Lilly's Zyprexa, the market leader, logged sales
of $1.05 billion for the quarter, up 15 percent. But US sales ...

AstraZeneca Boosts Forecast as Profit Beats Estimates (Update4)
Bloomberg - Jul 24, 2003
... the maker of the Prozac antidepressant, said net income rose 5.1 percent to $692.2
million, or 64 cents a share, on demand for the schizophrenia drug Zyprexa. ...

AstraZeneca Boosts Forecast as Profit Beats Estimates (Update3)
Bloomberg - Jul 24, 2003
... the maker of the Prozac antidepressant, said net income rose 5.1 percent to $692.2
million, or 64 cents a share, on demand for the schizophrenia drug Zyprexa. ...

UPDATE 3-Eli Lilly quarterly profit up, helped by Zyprexa
Reuters, UK - Jul 24, 2003
... based drugmaker as much as 3 percent. Global sales of Zyprexa for schizophrenia
rose 15 percent. Overseas sales jumped 45 percent to ...

Lilly, Bristol-Myers Have Solid Quarters
... The company's schizophrenia medication Zyprexa did $1.05 billion in revenue,
up 15%, while sales of its diabetes portfolio rose 4% to $640 million. ...

Eli Lilly's profit climbs, lifted by higher drug sales
CBS MarketWatch - Jul 24, 2003
... Lilly said revenue increased 11 percent to $3.09 billion, highlighted by a
15 percent increase in sales of anti-psychotic Zyprexa to $1.05 billion. ...

Lilly, Bristol Post Higher Profits; AstraZeneca Boosts Forecast
Bloomberg - Jul 24, 2003
... Lilly's competing Zyprexa product had sales of more than $1 billion,
pushing net income up 5.1 percent at Indianapolis- based Lilly. ...

RPT-UPDATE 1-Bristol-Myers earnings beat dismal 2002 results
Forbes - Jul 24, 2003
... from the company's new schizophrenia treatment, Abilify, which is stealing sales
from rival Eli Lilly and Co.'s (nyse: LLY - news - people) medicine Zyprexa.

Bristol-Myers earnings beat dismal 2002 results
USA Today - Jul 24, 2003
... Earnings got a hefty boost from the company's new schizophrenia treatment, Abilify,
which is stealing sales from rival Eli Lilly's medicine Zyprexa.

Eli Lilly Profit Rises, Helped by Zyprexa
FOX News - Jul 24, 2003
... unit of Reuters Group Plc. Global sales of Zyprexa (search) for schizophrenia
(search) rose 15 percent. Overseas sales jumped 45 ...

RPT-UPDATE 1-Bristol-Myers earnings beat dismal 2002 results
Reuters, UK - Jul 24, 2003
... got a hefty boost from the company's new schizophrenia treatment, Abilify, which
is stealing sales from rival Eli Lilly and Co.'s LLY.N medicine Zyprexa.

Bristol Myers 2Q rises
CNN - Jul 24, 2003
... Earnings got a hefty boost from the company's new schizophrenia treatment, Abilify,
which is stealing sales from rival Eli Lilly and Co.'s medicine Zyprexa.

Schizophrenia treatment boosts Lilly sales
Financial Times (subscription), UK - Jul 24, 2003
The US pharmaceutical company said second-quarter sales of Zyprexa rose 15 per
cent to just over $1bn, a record quarterly sales figure for the drug. ...

AstraZeneca Boosts Forecast as Profit Beats Estimates (Update2)
Bloomberg - Jul 24, 2003
... the maker of the Prozac antidepressant, said net income rose 5.1 percent to $692.2
million, or 64 cents a share, on demand for the schizophrenia drug Zyprexa. ...

Lilly, Bristol-Myers Have Solid Quarters
Real Money (subscription), NY - Jul 24, 2003
... The company's schizophrenia medication Zyprexa did $1.05 billion in revenue,
up 15%, while sales of its diabetes portfolio rose 4% to $640 million. ...

Eli Lilly Profit Rises, Helped by Zyprexa
Washington Post, DC - Jul 24, 2003
... Research, a unit of Reuters Group Plc. Global sales of Zyprexa for schizophrenia
rose 15 percent. Overseas sales jumped 45 percent to ...

Lilly Posts 5 Percent Earnings Gain in 2Q
Wilmington Morning Star, NC - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Eli Lilly Profit Rises, Helped by Zyprexa
MSN Money - Jul 24, 2003
... Research, a unit of Reuters Group Plc. Global sales of Zyprexa for schizophrenia
rose 15 percent. Overseas sales jumped 45 percent to ...

Eli Lilly Profit Rises, Helped by Zyprexa
Reuters, UK - Jul 24, 2003
... Research, a unit of Reuters Group Plc. Global sales of Zyprexa for schizophrenia
rose 15 percent. Overseas sales jumped 45 percent to ...

Eli Lilly Tops Guidance
Smart Money - Jul 24, 2003
... Among major sales drivers were Evista, the company's osteoporosis medicine, which
rose 19% to $223.5 million, and antipsychotic Zyprexa, the company's leading ...

Lilly posts 5 percent earnings gain
Indianapolis Star, IN - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Lilly Net Up 5.1% on Phychosis, Osteoporosis Drug Sales
Quicken - Jul 24, 2003
... Among major sales drivers were Evista, the company's osteoporosis medicine, which
rose 19% to $223.5 million, and antipsychotic Zyprexa, the company's leading ...

Lilly Posts 5 Percent Earnings Gain in 2Q
Newsday - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Lilly posts 5 percent earnings gain in 2Q
Penn Live, PA - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Lilly Posts 5 Percent Earnings Gain in 2Q
Times Daily, AL - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

AstraZeneca Boosts Forecast as Profit Beats Estimates (Update1)
Bloomberg - Jul 24, 2003
... the maker of the Prozac antidepressant, said net income rose 5.1 percent to $692.2
million, or 64 cents a share, on demand for the schizophrenia drug Zyprexa. ...

Lilly Posts 5 Percent Earnings Gain in 2Q
San Jose Mercury News, CA - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Lilly Posts 5 Percent Earnings Gain in 2Q
Sarasota Herald-Tribune, FL - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Lilly posts 5 percent earnings gain, beats Wall Street
Kansas City Star, MO - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Bristol-Myers Earnings Beat Dismal '02
Reuters, UK - Jul 24, 2003
... got a hefty boost from the company's new schizophrenia treatment, Abilify, which
is stealing sales from rival Eli Lilly and Co.'s LLY.N medicine Zyprexa.

Lilly posts 5 percent earnings gain, beats Wall Street
Miami Herald, FL - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Lilly posts 5 percent earnings gain, beats Wall Street
Akron Beacon Journal, OH - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Lilly posts 5 percent earnings gain, beats Wall Street
Fort Wayne News Sentinel, IN - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

Lilly posts 5 percent earnings gain, beats Wall Street
Wichita Eagle, KS - Jul 24, 2003
... Lilly said the second quarter was highlighted by a 15 percent increase in sales
of its top-selling drug, the antipsychotic Zyprexa, which recorded $1.05 ...

MOVERS & SHAKERS
CBS MarketWatch - Jul 24, 2003
... Reuters Research. Revenue rose 11 percent to $3.1 billion, amid strength
in sales of Zyprexa, Humalog, Gemzar and Evista. Gross ...

Eli Lilly second quarter tops forecasts
Business World, Ireland - Jul 24, 2003
The company reported second-quarter net income of USD692.2m and revenue rose 11pc
to USD3.1bn, amid strength in sales of its Zyprexa, Humalog, Gemzar and ...

Eli Lilly Profit Up, Helped by Zyprexa
Washington Post, DC - Jul 24, 2003
NEW YORK (Reuters) - Eli Lilly and Co. on Thursday said quarter earnings rose 5
percent, helped by strong sales of its top-selling schizophrenia medication. ...

Eli Lilly Profit Up, Helped by Zyprexa
MSN Money - Jul 24, 2003
NEW YORK (Reuters) - Eli Lilly and Co. on Thursday said quarter earnings rose 5
percent, helped by strong sales of its top-selling schizophrenia medication. ...

Eli Lilly Profit Up, Helped by Zyprexa
Reuters, UK - Jul 24, 2003
NEW YORK (Reuters) - Eli Lilly and Co. on Thursday said quarter earnings rose 5
percent, helped by strong sales of its top-selling schizophrenia medication. ...

Eli Lilly quarterly profit up, helped by Zyprexa
Forbes - Jul 24, 2003
NEW YORK (Reuters) - Eli Lilly and Co. Thursday said quarter earnings rose 5 percent,
helped by strong sales of its top-selling schizophrenia medication. ...

LILLY RECEIVES ADDITIONAL INDICATION FOR USE OF ZYPREXA WITH ...
Pharmexec (press release) - Jul 23, 2003
received Food and Drug Administration approval to market Zyprexa (olanzapine)
as a combination therapy to be used with lithium or Abbott Laboratories ...

Fake Lipitor is linked to suspect in Florida
Newark Star Ledger, NJ - Jul 21, 2003
... For example, while inspecting Medcom Pharmaceutical Wholesale Drugs in Jensen Beach,
Fla., in February, agents found 200 bottles of Zyprexa, a schizophrenia ...

As side effects mar patients, some put looks before health
Baltimore Sun, MD - Jul 21, 2003
... Some anti-schizophrenia drugs like Clozaril and Zyprexa trigger an average weight
gain of 15 pounds and sometimes 100 pounds or more, says Dr. Donald Goff, a ...

Health sense: Treatment can have unwanted effect
Minneapolis Star Tribune, MN - Jul 20, 2003
... Some anti-schizophrenia drugs such as Clozaril and Zyprexa trigger an average gain
of 15 pounds and sometimes, 100 pounds or more, says Dr. Donald Goff, a ...

[Click here to JOIN and get our WEEKLY newsletter!!]